ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SUMM Summit Therapeutics Plc

20.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Summit Therapeutics Plc LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 20.50 18.00 23.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Summit Therapeutics Share Discussion Threads

Showing 37176 to 37197 of 41850 messages
Chat Pages: Latest  1494  1493  1492  1491  1490  1489  1488  1487  1486  1485  1484  1483  Older
DateSubjectAuthorDiscuss
26/9/2016
16:10
Still here,feel btter looking a +% in the tdw a/c..

There must be a bigger sharerice here one day..
I remember selling AHT @34p at breakeven,after their big drop to 2p,averaged it back,,and what is it today,
had 20k of them,,to frightened to check,incase I go crackers....gla

abergele
26/9/2016
15:50
Me too Freedosh ... I guess when we were at almost £4 in 2013, i never thought we'd be where we'd be or see what we've seen of the share price this past year! GLA
hugus maximus
26/9/2016
15:50
Yes tightfist I believe that we could save a lot on costs to approval.
I just don't want to see RDZ being given away for a lot less than the value I put on it
Just hope we are not committed yet to either option at too low a price

freedosh
26/9/2016
15:45
Hi Freedosh,(Apologies if this was covered last week but) I saw your comment about the attractions of keeping RDZ and accepting some dilution. Does last week's news regarding the FDA and Sarepta open the door to a vastly reduced cost of taking ETD to market and hence that a modest dilution might enable retention of both ETD and RDZ? Or could a cash sale of limited RDZ geographic/market rights provide the necessary dosh?Just a thought, tightfist
tightfist
26/9/2016
15:36
Just bought 1k for the sipp as todays' news makes us a target for one of the big boys!!!
joeblogg2
26/9/2016
15:31
Not selling Hugus. I'm a long term holder for the big prize!
freedosh
26/9/2016
15:25
Approaching our average holding Freedosh .. bring it on.
hugus maximus
26/9/2016
15:11
Decent volume on Nasdaq , equal to 500k shares. Good call Freedosh.

Twitter alive with traders talking of SRPT buying us!

waterloo01
26/9/2016
14:52
The last time we rose like this we 5 bagged in 3 weeks, hope for the same again and then the deal announcement :)) Good luck all
jag63
26/9/2016
14:41
about bloody time i say !
m

maurillac
26/9/2016
14:34
currently opening on NASDAQ around 20% up!
hugus maximus
26/9/2016
14:16
Make that No. 10 now
freedosh
26/9/2016
14:15
Steadily climbing. Currently No. 16
16 minutes to NAS and potential take off

freedosh
26/9/2016
13:25
abergele

If you want to do a little reading, 45 pages, google AMR-Review.org Antibiotics. It's
from May this year and will give you the reason I feel we may still be underestimating
the potential value of RDZ, and why I would hope any deal done now, would include some
sort of clause to make sure SUMM get their fair share of any future world government
bounty.

kmjs
26/9/2016
12:55
Snap, Hugus, my break even is also £1.60 so have been heavily under water but relaxed as I look only to the future with total confidence in our portfolio.
freedosh
26/9/2016
12:43
Not sure what parallel health service Hip was working in but let's just take a fairly old orphan disease treatment for (mainly) children as an example. Gauchers enzyme replacement therapy Cerezyme costs around £100k pa. in the NHS. The company has introduced a new version costed at 320k dollars pa albeit in the US.
If we show clinical PoP we are likely to clean up since our drug is oral, so far without toxicity, and with low CoGs compared to the gene therapy alternatives. We can come in at say £100k pa , a fraction of the cost of the alternatives

Fast track designation will excite the US even more than here, IMO.

freedosh
26/9/2016
12:42
H.M.
I agree,I have another 10p at least to get to evens from,£1.50,,and we deserve a good wack profit for our patience...gla

abergele
26/9/2016
12:38
abergale ... sentiment is looking good but sadly like other investors who have been here for many years, my average is still some way further north. (£1.60 or 8p in long term holders early currency!)
hugus maximus
26/9/2016
12:36
Just watch this fly on the Nasdac this afternoon,,seatbelts fastened,and waiting..gla..we should/could see further moves in a response perhaps.
abergele
26/9/2016
12:28
We have gained over 50% in a week,,jolly nice for us holders,
but better still for the use of the drugs against these dire illneses out there.

abergele
26/9/2016
12:24
Well done waterloo01 & thanks for the post.It looks like the markets like the RNS currently up 16.5 (12.84%).
chrisatrdg
26/9/2016
12:21
Thanks Waterloo and Freedosh,nice explanation for me I must say,and echo your thoughts....
Yes we have been fortunate these past days ,so we can perhaps relax a little with our investments by all,does make you feel happy on a wet day here....gla

abergele
Chat Pages: Latest  1494  1493  1492  1491  1490  1489  1488  1487  1486  1485  1484  1483  Older

Your Recent History

Delayed Upgrade Clock